אוסטרליה - אנגלית - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - dexpanthenol; vitamin a palmitate; vitamin b12 = cyanocobalamin; vitamin b3 = nicotinamide; vitamin b2 phosphate sodium = riboflavin phosphate sodiu; vitamin b1 hydrochloride = thiamine hydrochloride; vitamin b6 hydrochloride = pyridoxine hydrochloride; vitamin d3 = cholecalciferol; dl-alpha-tocopheryl acetate (vitamin e); vitamin m = folic acid = pga - oral solution/suspension - dexpanthenol ungrouped active 3.33 mg/ml; vitamin a palmitate vitamin-a active 1.0 mg/ml; vitamin b12 = cyanocobalamin vitamin-b12 active 6.67 ug/ml; vitamin b3 = nicotinamide vitamin-b3 active 13.33 mg/ml; vitamin b2 phosphate sodium = riboflavin phosphate sodiu vitamin-b2 active 1.67 mg/ml; vitamin b1 hydrochloride = thiamine hydrochloride vitamin-b1 active 3.33 mg/ml; vitamin b6 hydrochloride = pyridoxine hydrochloride vitamin-b6 active 1.67 mg/ml; vitamin d3 = cholecalciferol vitamin-d3 active 0.1 mg/ml; dl-alpha-tocopheryl acetate (vitamin e) vitamin-e active 3.33 mg/ml; vitamin m = folic acid = pga vitamin-m active 0.5 mg/ml - nutrition & metabolism - horse - racehorse - mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

אוסטרליה - אנגלית - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sykes vet (international) pty. ltd. - calcium as calcium carbonate, di-calcium phosphate and c; cobalt as cobalt (ii) sulfate; copper (cu) present as copper sulfate; iron as ferrous sulfate; magnesium as magnesium sulfate; manganese as manganese (ii) sulfate; zinc as zinc oxide; vitamin a; vitamin c = ascorbic acid; vitamin d3; vitamin e; vitamin k3 - oral powder, pre-mix - calcium as calcium carbonate, di-calcium phosphate and c mineral-calcium active 333.3 g/kg; cobalt as cobalt (ii) sulfate mineral-cobalt active 1.1 g/kg; copper (cu) present as copper sulfate mineral-copper active 1.2 g/kg; iron as ferrous sulfate mineral-iron active 3.7 g/kg; magnesium as magnesium sulfate mineral-magnesium active 17.6 g/kg; manganese as manganese (ii) sulfate mineral-manganese active 7.3 g/kg; zinc as zinc oxide mineral-zinc active 3.2 g/kg; vitamin a vitamin-a active 900000.0 iu/kg; vitamin c = ascorbic acid vitamin-c active 5390.0 mg/kg; vitamin d3 vitamin-d3 active 1200.0 mg/kg; vitamin e vitamin-e active 2600.0 iu/kg; vitamin k3 vitamin-k3 active 750.0 mg/kg - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - calcium supplement | iron deficiency | phosphorus deficiency | vitamin & mineral deficiency | anaemia

ניו זילנד - אנגלית - Ministry for Primary Industries

zoetis new zealand limited - vitamin e acetate; pyridoxine hydrochloride; vitamin b2 (riboflavin); thiamine hydrochloride; vitamin a; l-methionine; vitamin c (ascorbic acid); thioctic acid; calcium pantothenate; norethandrolone; magnesium phosphate tribasic; calcium phosphate dibasic; niacinamide; cholecalciferol - vitamin e acetate 2.95 g/kg; pyridoxine hydrochloride 0.6 g/kg; vitamin b2 (riboflavin) 2 g/kg; thiamine hydrochloride 4.4 g/kg; vitamin a 4.6 g/kg; l-methionine 14.8 g/kg; vitamin c (ascorbic acid) 59.1 g/kg; thioctic acid 2.95 g/kg; calcium pantothenate 4.4 g/kg; norethandrolone 14.8 g/kg; magnesium phosphate tribasic 146 g/kg; calcium phosphate dibasic 583.4 g/kg; niacinamide 14.8 g/kg; cholecalciferol 0.03 g/kg - endocrine agent (hormone)

קנדה - אנגלית - Health Canada

gfr pharma ltd. - nicotinamide; vitamin b1 (thiamine mononitrate); vitamin b2 (riboflavin); d-pantothenic acid (calcium d-pantothenate); vitamin b6 (pyridoxine hydrochloride); folic acid; vitamin b12 (cyanocobalamin); biotin; choline (choline bitartrate); inositol - tablet - 50mg; 50mg; 50mg; 50mg; 50mg; 0.1mg; 50mcg; 50mcg; 50mg; 50mg - nicotinamide 50mg; vitamin b1 (thiamine mononitrate) 50mg; vitamin b2 (riboflavin) 50mg; d-pantothenic acid (calcium d-pantothenate) 50mg; vitamin b6 (pyridoxine hydrochloride) 50mg; folic acid 0.1mg; vitamin b12 (cyanocobalamin) 50mcg; biotin 50mcg; choline (choline bitartrate) 50mg; inositol 50mg - vitamin b complex

ארצות הברית - אנגלית - NLM (National Library of Medicine)

golden state medical supply, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate.  animal reproduction studies have not been conducted with calcium acetate capsules, and there are no adequate and well controlled studies of calcium acetate capsules use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism.  calcium acetate capsules treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effec

ארצות הברית - אנגלית - NLM (National Library of Medicine)

nostrum laboratories, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate.  animal reproduction studies have not been conducted with calcium acetate capsules, and there are no adequate and well controlled studies of calcium acetate capsules use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism.  calcium acetate capsules treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium a

ארצות הברית - אנגלית - NLM (National Library of Medicine)

state of florida doh central pharmacy - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate gelcaps is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate gelcaps contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are

ארצות הברית - אנגלית - NLM (National Library of Medicine)

paddock laboratories, llc - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate tablets, usp are indicated for the control of hyperphosphatemia in end stage renal failure and does not promote aluminum absorption. patients with hypercalcemia.

ארצות הברית - אנגלית - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate tablet is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate.  animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are

ארצות הברית - אנגלית - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate tablet is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate.  animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism.  calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are